The role of glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes-Reference-Cited by-同舟云学术

The role of glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

Published:2017-06-01 Issue:2 Volume:5 Page:79-89
ISSN:2224-4018
Container-title:Journal of Translational Internal Medicine
language:en
Short-container-title:

Author:

St Onge Erin¹,Miller Shannon¹,Clements Elizabeth²,Celauro Lindsay²,Barnes Ke’la²

Affiliation:

1. University of Florida , College of Pharmacy , Florida , USA

2. Florida Hospital Celebration Health , Florida , USA

Abstract

Abstract The role of GLP-1 agonists in the treatment of type 2 diabetes have been shown to be viable options for add-on therapy in diabetic patients, as well as potential monotherapy options. With six available GLP-1 agents, and new combination products in the pipeline, they are a promising drug class for type 2 diabetic patients, especially due to their extended dosing interval and potential weight loss benefits.

Publisher

Walter de Gruyter GmbH

Subject

Internal Medicine

Reference60 articles.

1. American Diabetes Association. Statistics about diabetes (April 2016). Available at: http://www.diabetes.org/diabetes-basics/statistics. Accessed on October 17, 2016.

2. American Diabetes Association. Standards of medical care in diabetes – 2016. Diabetes Care 2016;39:S1-112.

3. Jellinger, PS. Focus on Incretin-Based Therapies: Targeting the Core Defects of Type 2 Diabetes. Postgrad Med 2011;121:53-65.

4. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2016 executive summary. Endocr Pract 2016;22;84-113.

5. Vilsbøll T, Holst JJ. Incretins, insulin secretion and type 2 diabetes mellitus. Diabetologia 2004;47:357–66.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Approaches and Challenges;Nanoscience Applications in Diabetes Treatment;2023-12-17

2. Type II diabetes mellitus: a review on recent drug based therapeutics;Biomedicine & Pharmacotherapy;2020-11

3. Improved Clinical Outcomes with Dulaglutide as Add-on Medication to Oral Antidiabetic Drugs with or Without Insulin in Overweight Indian Patients with Type 2 Diabetes Mellitus: Retrospective Study in a Real-World Setting;Current Diabetes Reviews;2020-05-12

4. Small cell lung cancer starting with diabetes mellitus: Two case reports and literature review;World Journal of Clinical Cases;2019-05-26

5. A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes;Diabetes Therapy;2018-11-30